Filtreeri Last updated date SelectPärastEnneFrom - To Date Lõppkuupäev This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Tulemused (3841) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Second Meeting of the Management Board of the European Agency for the Evaluation of Medicinal Products 13 aprill 1994Press releaseCorporate 1 … 377 378 379 380 381 382 383 384 385 Page 385 of 385
Second Meeting of the Management Board of the European Agency for the Evaluation of Medicinal Products 13 aprill 1994Press releaseCorporate
